Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil Once Daily in PDE5i Naïve ED
NCT00836693Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of tadalafil in erectile dysfunction (ED), sponsored by Eli Lilly and Company. Started Jan 2009; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00836693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00836693.